[Translation] An open-label, phase I study evaluating the safety, radiation dosimetry, and pharmacokinetics of 89Zr-TLX250 PET/CT in patients with indeterminate renal masses or suspected recurrent clear cell renal cell carcinoma (ZIRDOSE-CP study)
主要目的
评估89Zr-TLX250的安全性和耐受性
次要目的
分析89Zr-TLX250在中国不确定性肾肿块或疑似复发的肾透明细胞癌(ccRCC)患者中的药代动力学(PK)、生物分布和剂量学
[Translation] main purpose
To evaluate the safety and tolerability of 89Zr-TLX250
secondary purpose
Analysis of Pharmacokinetics (PK), Biodistribution and Dosimetry of 89Zr-TLX250 in Chinese Patients with Indeterminate Renal Mass or Suspected Recurrent Clear Cell Renal Carcinoma (ccRCC)